tiprankstipranks
Adapthealth (AHCO)
NASDAQ:AHCO
US Market
AHCO
AdaptHealth
RESEARCH TOOLSreports
Want to see AHCO full AI Analyst Report?

AdaptHealth (AHCO) Stock Forecast & Price Target

335 Followers
See the Price Targets and Ratings of:

AHCO Analyst Ratings

Moderate Buy
7Ratings
Moderate Buy
5 Buy
2 Hold
0 Sell
Based on 7 analysts giving stock ratings to
AdaptHealth
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

AHCO Stock 12 Month Forecast

Average Price Target

$13.93
▲(10.02% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for AdaptHealth in the last 3 months. The average price target is $13.93 with a high forecast of $18.00 and a low forecast of $9.50. The average price target represents a 10.02% change from the last price of $12.66.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"7":"$7","10":"$10","13":"$13","16":"$16","19":"$19"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":18,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$18.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13.928571428571427,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$13.93</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$9.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[7,10,13,16,19],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.17,13.541538461538462,13.913076923076924,14.284615384615385,14.656153846153845,15.027692307692307,15.399230769230769,15.77076923076923,16.142307692307693,16.513846153846153,16.885384615384616,17.256923076923076,17.628461538461536,{"y":18,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.17,13.228351648351648,13.286703296703296,13.345054945054944,13.403406593406594,13.461758241758242,13.52010989010989,13.578461538461537,13.636813186813185,13.695164835164833,13.753516483516481,13.811868131868131,13.870219780219779,{"y":13.928571428571427,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.17,12.887692307692308,12.605384615384615,12.323076923076924,12.04076923076923,11.758461538461539,11.476153846153846,11.193846153846154,10.911538461538461,10.62923076923077,10.346923076923076,10.064615384615385,9.782307692307693,{"y":9.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":8.5,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.75,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.4,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.75,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.15,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.11,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.99,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.75,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.96,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.1,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.64,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.86,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.17,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$18.00Average Price Target$13.93Lowest Price Target$9.50
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on AHCO
Ben Hendrix
RBC Capital
RBC Capital
$13→$15
Buy
18.48%
Upside
Reiterated
05/08/26
AdaptHealth (AHCO) Gets a Buy from RBC Capital
Truist Financial Analyst forecast on AHCO
David S Macdonald
Truist Financial
Truist Financial
$14
Buy
10.58%
Upside
Reiterated
05/06/26
Truist Financial Sticks to Their Buy Rating for AdaptHealth (AHCO)
Canaccord Genuity Analyst forecast on AHCO
Richard Close
Canaccord Genuity
Canaccord Genuity
$14→$16
Buy
26.38%
Upside
Reiterated
05/06/26
AdaptHealth price target raised to $16 from $14 at CanaccordAdaptHealth price target raised to $16 from $14 at Canaccord
Robert W. Baird Analyst forecast on AHCO
Eric Coldwell
Robert W. Baird
Robert W. Baird
$17→$18
Buy
42.18%
Upside
Reiterated
05/06/26
AdaptHealth price target raised to $18 from $17 at BairdAdaptHealth price target raised to $18 from $17 at Baird
UBS Analyst forecast on AHCO
Kevin Caliendo
UBS
UBS
$15→$14
Buy
10.58%
Upside
Reiterated
05/06/26
AdaptHealth price target lowered to $14 from $15 at UBSAdaptHealth price target lowered to $14 from $15 at UBS
Jefferies Analyst forecast on AHCO
Brian Tanquilut
Jefferies
Jefferies
$9.5→$11
Hold
-13.11%
Downside
Reiterated
04/20/26
AdaptHealth price target raised to $11 from $9.50 at JefferiesAdaptHealth price target raised to $11 from $9.50 at Jefferies
Deutsche Bank Analyst forecast on AHCO
Pito Chickering
Deutsche Bank
Deutsche Bank
$10.5→$9.5
Hold
-24.96%
Downside
Reiterated
02/25/26
AdaptHealth price target lowered to $9.50 from $10.50 at Deutsche BankAdaptHealth price target lowered to $9.50 from $10.50 at Deutsche Bank
Leerink Partners Analyst forecast on AHCO
Whit Mayo
Leerink Partners
Leerink Partners
$13
Buy
2.69%
Upside
Reiterated
08/13/25
AdaptHealth's Positive Trajectory and Strategic Growth Support Buy Rating
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on AHCO
Ben Hendrix
RBC Capital
RBC Capital
$13→$15
Buy
18.48%
Upside
Reiterated
05/08/26
AdaptHealth (AHCO) Gets a Buy from RBC Capital
Truist Financial Analyst forecast on AHCO
David S Macdonald
Truist Financial
Truist Financial
$14
Buy
10.58%
Upside
Reiterated
05/06/26
Truist Financial Sticks to Their Buy Rating for AdaptHealth (AHCO)
Canaccord Genuity Analyst forecast on AHCO
Richard Close
Canaccord Genuity
Canaccord Genuity
$14→$16
Buy
26.38%
Upside
Reiterated
05/06/26
AdaptHealth price target raised to $16 from $14 at CanaccordAdaptHealth price target raised to $16 from $14 at Canaccord
Robert W. Baird Analyst forecast on AHCO
Eric Coldwell
Robert W. Baird
Robert W. Baird
$17→$18
Buy
42.18%
Upside
Reiterated
05/06/26
AdaptHealth price target raised to $18 from $17 at BairdAdaptHealth price target raised to $18 from $17 at Baird
UBS Analyst forecast on AHCO
Kevin Caliendo
UBS
UBS
$15→$14
Buy
10.58%
Upside
Reiterated
05/06/26
AdaptHealth price target lowered to $14 from $15 at UBSAdaptHealth price target lowered to $14 from $15 at UBS
Jefferies Analyst forecast on AHCO
Brian Tanquilut
Jefferies
Jefferies
$9.5→$11
Hold
-13.11%
Downside
Reiterated
04/20/26
AdaptHealth price target raised to $11 from $9.50 at JefferiesAdaptHealth price target raised to $11 from $9.50 at Jefferies
Deutsche Bank Analyst forecast on AHCO
Pito Chickering
Deutsche Bank
Deutsche Bank
$10.5→$9.5
Hold
-24.96%
Downside
Reiterated
02/25/26
AdaptHealth price target lowered to $9.50 from $10.50 at Deutsche BankAdaptHealth price target lowered to $9.50 from $10.50 at Deutsche Bank
Leerink Partners Analyst forecast on AHCO
Whit Mayo
Leerink Partners
Leerink Partners
$13
Buy
2.69%
Upside
Reiterated
08/13/25
AdaptHealth's Positive Trajectory and Strategic Growth Support Buy Rating
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering AdaptHealth

3 Months
Richard CloseCanaccord Genuity
Success Rate
14/26 ratings generated profit
54%
Average Return
+3.85%
Copying Richard Close's trades and holding each position for 3 Months would result in 53.85% of your transactions generating a profit, with an average return of +3.85% per trade.
1 Year
Richard CloseCanaccord Genuity
Success Rate
11/26 ratings generated profit
42%
Average Return
-10.43%
Copying Richard Close's trades and holding each position for 1 Year would result in 42.31% of your transactions generating a profit, with an average return of -10.43% per trade.
2 Years
Richard CloseCanaccord Genuity
Success Rate
11/26 ratings generated profit
42%
Average Return
-11.38%
Copying Richard Close's trades and holding each position for 2 Years would result in 42.31% of your transactions generating a profit, with an average return of -11.38% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

AHCO Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
1
1
1
1
1
Buy
4
3
2
3
5
Hold
0
1
1
2
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
5
4
6
7
In the current month, AHCO has received 6 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. AHCO average Analyst price target in the past 3 months is 13.93.
Each month's total comprises the sum of three months' worth of ratings.

AHCO Financial Forecast

AHCO Earnings Forecast

Next quarter’s earnings estimate for AHCO is $0.15 with a range of $0.03 to $0.25. The previous quarter’s EPS was -$0.06. AHCO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year AHCO has Performed in-line its overall industry.
Next quarter’s earnings estimate for AHCO is $0.15 with a range of $0.03 to $0.25. The previous quarter’s EPS was -$0.06. AHCO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year AHCO has Performed in-line its overall industry.

AHCO Sales Forecast

Next quarter’s sales forecast for AHCO is $848.59M with a range of $825.40M to $861.62M. The previous quarter’s sales results were $819.80M. AHCO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year AHCO has Performed in-line its overall industry.
Next quarter’s sales forecast for AHCO is $848.59M with a range of $825.40M to $861.62M. The previous quarter’s sales results were $819.80M. AHCO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year AHCO has Performed in-line its overall industry.

AHCO Stock Forecast FAQ

What is AHCO’s average 12-month price target, according to analysts?
Based on analyst ratings, Adapthealth’s 12-month average price target is 13.93.
    What is AHCO’s upside potential, based on the analysts’ average price target?
    Adapthealth has 10.02% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is AHCO a Buy, Sell or Hold?
          Adapthealth has a consensus rating of Moderate Buy which is based on 5 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Adapthealth’s price target?
            The average price target for Adapthealth is 13.93. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $18.00 ,the lowest forecast is $9.50. The average price target represents 10.02% Increase from the current price of $12.66.
              What do analysts say about Adapthealth?
              Adapthealth’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of AHCO?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.